Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1796 of 6351
-
Lupus drug may shield heart and arteries
Disease control Recruiting nowBackground: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Objective: To test w…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a tiny implant replace monthly eye shots for wet AMD?
Disease control OngoingThe primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular age-related macular degeneration (nAMD).
Phase 1/2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Smart prosthetic legs learn to walk naturally
Knowledge-focused Recruiting nowThe overall goal of this project is to model human joint biomechanics over continuously-varying locomotion to enable adaptive control of powered above-knee prostheses. The central hypothesis of this project is that variable joint impedance can be parameterized by a continuous mod…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Virtual reality may help kids with autism learn social skills
Symptom relief CompletedThe goal of this clinical trial is to learn whether a virtual reality (VR)-based social skills intervention works as well as an in-person group intervention for improving social skills in preschool children with autism spectrum disorder (ASD) without intellectual disability. It w…
Sponsor: National Cheng-Kung University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Spinal stimulation showdown: which technique helps paralyzed patients stand?
Knowledge-focused Recruiting nowIt has been demonstrated that the human lumbosacral spinal cord can be neuromodulated with epidural (ESS) and transcutaneous (TSS) spinal cord stimulation to enable recovery of standing and volitional control of the lower limbs after complete motor paralysis due to spinal cord in…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New radioactive nanoparticle targets tough tumors in early trial
Disease control Recruiting nowThe purpose of this first-in-human (FIH) study is to determine the maximum tolerated dose (MTD) and to characterize the safety, tolerability, PK, and dosimetry profile of \[177Lu\]Lu-SN201 in adult participants with advanced solid tumors who have no standard of care treatment opt…
Phase 1/2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a wearable predict heart failure Flare-Ups before they happen?
Knowledge-focused Stopped earlyThis study will assess the deployment of the ADI CPM System in a home setting and determine the interoperability of the CPM System within existing care pathways for HF patients. Clinicians will be blinded to CPM generated data and acquired physiologic data will not be used in cli…
Sponsor: Analog Device, Inc. • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat colon cancer mutation
Disease control OngoingTo find the recommended dose of MRTX849 that can be given in combination with cetuximab and irinotecan to patients with colorectal cancer that have a mutation (genetic change) called KRAS G12C.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
A wearable sensor may soon read your body's response to food
Knowledge-focused CompletedThe goal of this clinical trial is to establish the relationship between macronutrient food intake and the resulting blood and intersticial fluid (ISF )levels of small molecule markers, as well as, validate wearable optical readers and data fusion algorithms to accurately predict…
Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
AI and a smartphone app may let kids with asthma skip clinic visits
Disease control CompletedThe main purpose of this study is to look at whether clinicians and their patients with asthma can satisfactorily perform remote asthma management at home (not visiting clinic) by using an artificial intelligence tool called Asthma-Guidance and Prediction System combined with a h…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a new pill quiet chronic pain? early trial puts it to the test
Knowledge-focused CompletedThe purpose of this randomized, double-blind, placebo-controlled Phase 1 study was to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of AJH-2947 in healthy Korean or Caucasian adult male participants.
Phase 1 • Sponsor: JMackem Co., Ltd • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo trial targets Hard-to-Treat breast and ovarian cancers
Disease control Recruiting nowThis study is designed to evaluate AZD8421 alone and in combination with selected targeted anti-cancer drugs in patients with ER+HER2- advanced breast cancer, and patients with metastatic high-grade serious ovarian cancer.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug AZD0305 takes on multiple myeloma in early trial
Disease control Recruiting nowThis is a Phase I/II, modular, open-label, multicenter, dose escalation, and dose expansion/optimization study to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics and efficacy of AZD0305 as monotherapy and in combination with other anticancer agents in part…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New anthrax vaccine moves forward in human trials
Vaccine OngoingThis randomized, phase 2, double-blinded, multicenter study is designed to assess the safety and immune response kinetics of CYFENDUS™ (henceforth AV7909) administered on 2 primary series vaccination schedules followed by 6- and 12-month boosters.
Phase 2 • Sponsor: Biomedical Advanced Research and Development Authority • Aim: Vaccine
Last updated Jun 27, 2026 09:07 UTC
-
Could a Low-Calorie diet ease heart failure symptoms?
Disease control CompletedHeart failure with preserved ejection fraction (HFpEF) is a common and serious complication of obesity and type 2 diabetes (T2D). HFpEF occurs when the heart muscle unable to relax efficiently to pump the blood around the body. This leads to fluid build-up, breathlessness and ina…
Phase 2/3 • Sponsor: University of Leicester • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThe goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with tilpisertib fosmecar…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy aims to curb meth use in canadian trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if administering a high dose stimulant with Contingency Management reduces days of use in adults who use methamphetamine better than the usual treatment provided by the clinic. The main questions the trial aims to answer are: Is a hig…
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New laser device aims to lower eye pressure better in glaucoma surgery trial
Disease control Recruiting nowThe primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.
Sponsor: Elios Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New brain bleed treatment shows promise in massive review
Disease control Recruiting nowThis multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New electric pulse method tested for stubborn heart rhythm disorder
Disease control OngoingComparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persistent atrial fibrillation.
Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC